iifl-logo

Sun Pharmaceuticals Industries Ltd Historical Data

1,687.6
(1.07%)
Jun 27, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sun Pharmaceuticals Industries Ltd Historical Data

28/05/2025calendar-icon
28/06/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

29-May-2025

1,675

1,703.31,670.41,699.81,26,1014,01,96,78,075.314,59,692

30-May-2025

1,702

1,713.61,669.11,677.691,3986,13,10,78,417.326,11,830

02-Jun-2025

1,679

1,683.51,660.51,674.696,5653,04,55,87,489.213,04,180

03-Jun-2025

1,695

1,6951,657.61,667.51,10,8384,26,49,41,89515,41,709

04-Jun-2025

1,656

1,6691,6491,664.964,4332,82,58,80,489.210,20,975

05-Jun-2025

1,662

1,694.31,6621,683.197,2173,42,38,04,103.712,03,563

06-Jun-2025

1,685

1,6891,6691,679.298,4714,19,12,08,633.518,52,030

09-Jun-2025

1,679.9

1,698.81,673.31,694.462,2704,35,58,55,57319,79,519

10-Jun-2025

1,701.8

1,706.91,677.71,688.873,6203,99,78,60,997.714,95,109

11-Jun-2025

1,694.8

1,6951,679.31,690.667,4403,37,49,55,992.713,33,427

12-Jun-2025

1,694.9

1,727.51,681.11,687.41,44,7236,11,82,17,309.215,68,676

13-Jun-2025

1,666.8

1,7001,661.11,687.896,5144,04,91,80,141.315,94,376

16-Jun-2025

1,665

1,689.81,655.71,685.369,7153,78,05,66,432.512,19,348

17-Jun-2025

1,680

1,681.71,641.11,650.21,93,3108,93,51,61,142.234,34,579

18-Jun-2025

1,645

1,661.31,638.51,64878,0992,40,01,76,169.77,65,864

19-Jun-2025

1,648.1

1,655.31,6361,647.674,6122,79,39,27,225.47,96,786

20-Jun-2025

1,647.6

1,6701,645.61,665.159,4364,27,19,66,103.219,10,139

23-Jun-2025

1,663.2

1,6671,647.21,662.546,1911,39,38,66,514.84,83,519

24-Jun-2025

1,670.5

1,686.41,658.81,661.790,3983,45,04,50,084.111,91,123

25-Jun-2025

1,661.7

1,678.81,658.11,669.667,2712,29,40,93,649.48,71,169

26-Jun-2025

1,674.8

1,678.91,650.41,669.878,6463,49,91,12,694.410,94,463

27-Jun-2025

1,670.2

1,695.71,668.21,687.698,8818,94,55,59,886.444,48,718

Sun Pharma.Inds.: Related NEWS

Top Stocks for Today - 16th June 2025
16 Jun 2025|06:23 AM

Here are some of the stocks that may see significant price movement today: Sun Pharma, Vedanta, SpiceJet, etc.

Read More
US FDA Flags 8 Observations at Sun Pharma’s Halol Facility After GMP Inspection
15 Jun 2025|11:50 PM

The visit lasted from June 2 to June 13 and focused on checking for compliance with Good Manufacturing Practices.

Read More
Sun Pharma Expands Specialty Drug Pipeline with $25 Million Pharmazz Deal
24 May 2025|07:51 PM

Both treatments have already received approvals in India and are available for sale there with local partners under a brand known as Tyvalzi and Lyfaquin.

Read More
Sun Pharma Q4 FY25 Revenue Rises 8.5% to ₹12,816 Crore
23 May 2025|12:07 PM

The Board recommended a final dividend of ₹5.50 per share for FY25.

Read More
Top Stocks for Today - 7th May 2025
7 May 2025|08:06 AM

NLC's subsidiary has executed a PPA with Rajasthan Rajya Vidyut Utpadan Nigam Ltd. (RVUNL) for 810 MW solar power plant at Pugal Solar Park, Rajasthan

Read More
Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis
26 Apr 2025|01:15 PM

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

Read More
Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million
10 Mar 2025|10:46 AM

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

Read More
Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend
31 Jan 2025|10:17 PM

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

Read More
Sun Pharma reports Q2 net profit at ₹3,040 Crore
29 Oct 2024|10:30 AM

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Read More
Sun Pharma's Hair Loss Drug Approved by USFDA
26 Jul 2024|01:45 PM

The US Food and Drug Administration (USFDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets, according to a regulatory filing.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.